Literature DB >> 2682461

Activated ras genes in human seminoma: evidence for tumor heterogeneity.

M P Mulder1, W Keijzer, A Verkerk, A J Boot, M E Prins, T A Splinter, J L Bos.   

Abstract

The incidence of mutations in cellular ras genes was determined in human seminoma, a germ cell tumor of the testis, with the aid of specific oligonucleotide probe hybridization. To eliminate the large number of nonneoplastic cells present in seminomas, aneuploid tumor cell nuclei were isolated from the tumor tissue by flow sorting. Mutations were detected in 40% of the seminomas at codons 12 or 61 of either the Ki-ras or the N-ras gene. No correlation was found with histopathological or clinical features. In some seminomas the mutant gene was present in only a fraction of the tumor cell population, suggesting tumor heterogeneity for ras gene mutations. Yet, flow cytometric measurement of nuclear DNA contents and histological examination of tumor tissue did not reveal two different tumor cell populations. We conclude from these observations that ras mutation is probably not the initial genetic event in the development of seminoma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2682461

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Ras gene activation in malignant cells of human ovarian carcinoma peritoneal fluids.

Authors:  D N Dokianakis; M N Varras; M Papaefthimiou; J Apostolopoulou; H Simiakaki; E Diakomanolis; D A Spandidos
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

Review 2.  Molecular biology of testicular germ cell tumors: current status.

Authors:  B Schmidt; R Ackermann; T Strohmeyer
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

3.  hH-Rev107, a class II tumor suppressor gene, is expressed by post-meiotic testicular germ cells and CIS cells but not by human testicular germ cell tumors.

Authors:  S Siegrist; C Féral; M Chami; B Solhonne; M G Mattéi; E Rajpert-De Meyts; G Guellaën; F Bulle
Journal:  Oncogene       Date:  2001-08-23       Impact factor: 9.867

4.  Enforced expression of Simian virus 40 large T-antigen leads to testicular germ cell tumors in zebrafish.

Authors:  James A Gill; Linda Lowe; Joan Nguyen; P Paul Liu; Trevor Blake; Byrappa Venkatesh; Peter D Aplan
Journal:  Zebrafish       Date:  2010-12       Impact factor: 1.985

Review 5.  Molecular mechanisms of testicular carcinogenesis.

Authors:  D B Rukstalis
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 6.  [Value of targeted treatment for testicular cancer: from molecular approaches to clinical possibilities].

Authors:  A Martinschek; C G Ruf; C Sparwasser; H U Schmelz
Journal:  Urologe A       Date:  2008-10       Impact factor: 0.639

7.  Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors.

Authors:  D Chatterjee; C J Liu; D Northey; B A Teicher
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Ha-ras gene codon 12 mutation and DNA ploidy in urinary bladder carcinoma.

Authors:  B Czerniak; D Deitch; H Simmons; P Etkind; F Herz; L G Koss
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

9.  K-ras oncogene codon 12 point mutations in testicular cancer.

Authors:  M Ridanpää; R A Lothe; A Onfelt; S Fosså; A L Børresen; K Husgafvel-Pursiainen
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

10.  Oncogenes in human testicular cancer: DNA and RNA studies.

Authors:  P Peltomäki; O Alfthan; A de la Chapelle
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.